Trial Profile
Plerixafor MM02 - Plerixafor plus G-CSF after chemotherapy for the mobilization of Peripheral Blood Stem Cells (PBSCs) in Multiple Myeloma (MM) patients undergoing Autologous Stem Cell Transplantation (ASCT)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2014
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary) ; Cyclophosphamide; Filgrastim; Lenograstim
- Indications Multiple myeloma
- Focus Pharmacodynamics
- 30 Jun 2014 New trial record